[51867] in Discussion of MIT-community interests
Pulmonary Disease | COPD Treatment Options - (mit-talk-mtg@charon.mit.edu)
daemon@ATHENA.MIT.EDU (COPD Treatment)
Fri Aug 28 13:16:47 2015
Date: Fri, 28 Aug 2015 10:16:42 -0700
From: "COPD Treatment" <10926@xavopij.eu>
To: <mit-talk-mtg@charon.mit.edu>
------=Part.508.6953.1440782202
Content-Transfer-Encoding: 8bit
Content-Type: text/plain; charset="UTF-8"
Fri, 28 Aug 2015 10:16:42 -0700
Pulmonary Disease | COPD Treatment Options - (mit-talk-mtg@charon.mit.edu)
Pulmonary Disease | COPD Treatment Options | Learn About Symptoms and Diagnosis
LEARN MORE IN SPONSORED LISTINGS
http://obi.xavopij.eu/ec.php?k=1111&kc=3691375&ks=29114&kf=10926&pc=1238&tt=1&t1=&t2=&t3=&t4=api3-recol-network-3-a-3&u=7ea99ed1b6714702bd5343b786c98bee&u2=&aurid=55e094e0a581e3d955e094e076b2e9ba&mdom=Y2hhcm9uLm1pdC5lZHU%3D
PO Box 540901
Houston, TX 77254
unsubscribe - http://obi.xavopij.eu/u.php
------=Part.508.6953.1440782202
Content-Transfer-Encoding: 8bit
Content-Type: text/html; charset="UTF-8"
<html>
<head>
<title>Pulmonary Disease | COPD Treatment Options - (mit-talk-mtg@charon.mit.edu)</title>
<style type="text/css" media="all">
#body
{
background-color: rgb(255,255,255);
color: rgb(36,56,68);
font-family: Times New Roman, serif;
border-left-width: 0px; border-right-width: 0px; border-top-width: 0px; border-bottom-width: 0px;
border-left-style: none; border-right-style: none; border-top-style: none; border-bottom-style: none;
border-color: rgb(70,88,116);
}
#content
{
font-size: 94%;
background-color: rgb(0,0,0);
color: rgb(70,88,116);
border-left-width: 0px; border-right-width: 0px; border-top-width: 0px; border-bottom-width: 0px;
border-left-style: none; border-right-style: none; border-top-style: none; border-bottom-style: none;
padding: 47px 47px 47px 47px;
border-color: rgb(0,0,0);
text-align: left;
}
#menu
{
background-color: rgb(255,255,255);
color: rgb(167,164,218);
font-family: Times New Roman, serif;
font-style: normal;
border-color: rgb(167,164,218);
}
#a.menuitem
{
font-size: 150%;
background-color: rgb(36,56,68);
color: rgb(163,189,208);
font-variant: normal;
text-transform: none;
font-weight: bold;
margin-left: 5px; margin-right: 5px; margin-top: 5px; margin-bottom: 5px;
border-left-width: 0px; border-right-width: 0px; border-top-width: 0px; border-bottom-width: 0px;
border-left-style: none; border-right-style: none; border-top-style: none; border-bottom-style: none;
border-color: rgb(167,164,218);
text-align: center;
}
#logo, #logo a
{
font-size: 176%;
background-color: rgb(255,255,255);
color: rgb(36,56,68);
font-family: Times New Roman, serif;
font-style: normal;
font-variant: normal;
text-transform: none;
font-weight: normal;
text-indent: 31;
padding: 2px 2px 2px 2px;
border-color: rgb(38,150,172);
text-align: left;
}
#trail, #trail a
{
font-size: 98%;
background-color: rgb(0,0,0);
color: rgb(38,150,172);
font-style: italic;
font-variant: normal;
text-transform: none;
font-weight: bold;
border-left-width: 8px; border-right-width: 8px; border-top-width: 8px; border-bottom-width: 8px;
border-left-style: groove; border-right-style: groove; border-top-style: groove; border-bottom-style: groove;
padding: 13px 10px 13px 10px;
border-color: rgb(70,88,116);
text-align: left;
}
#content a
{
color: rgb(255,255,255);
text-decoration: underline;
}
#content a:hover, #content a:active
{
background-color: rgb(255,255,255);
color: rgb(0,0,0);
}
#h1, h2, h3, h4, h5, h6
{
font-family: Times New Roman, serif;
font-style: normal;
font-variant: normal;
text-transform: none;
font-weight: normal;
}
#h1
{
font-size: 134%;
}
#h2
{
font-size: 120%;
}
#h3
{
font-size: 106%;
}
#h4
{
font-size: 92%;
}
#h5
{
font-size: 78%;
}
#h6
{
font-size: 64%;
}
#trail a
{
text-decoration: underline;
}
#logo a
{
text-decoration: none;
}
#menu a
{
text-decoration: none;
}
#trail a:hover
{
}
#.menuitem:hover
{
background-color: rgb(163,189,208);
color: rgb(36,56,68);
}
#menu {width: 20%; position: relative; top: 0; right: 0; float: right; text-align: center;}
#.menuitem {width: auto;}
#content {margin-right: 20%; width: auto}
#.menuitem {display: block;}
#@media print
{
#menu {display: none;}
#content {padding: 0px;}
#content a {text-decoration: underline;}
}
</style>
</head>
<body>
<!-- <div style="position:absolute;top:-1000px;left:-1000px;height:0px;width:0px;"><img src="http://www.xavopij.eu/timgSILPOSHTP/YIAWDCYIV/2856/176/322/17/22529568/img.gif" style="border=0;" /></div> -->
<div style="position:absolute;top:-1000px;left:-1000px;height:0px;width:0px;"><a href="http://www.xavopij.eu/trUSBPSTXHQ/BEYHJNMLG/2856/176/322/17/22529568/index.htm" style="border=0;"><div></div></a></div>
<br />
<body><p><a href="http://obi.xavopij.eu/ec.php?k=1111&kc=3691375&ks=29114&kf=10926&pc=1238&tt=1&t1=&t2=&t3=&t4=api3-recol-network-3-a-3&u=7ea99ed1b6714702bd5343b786c98bee&u2=&aurid=55e094e0a581e3d955e094e076b2e9ba&mdom=Y2hhcm9uLm1pdC5lZHU%3D">Pulmonary Disease Resources</a></p><p><a href="http://obi.xavopij.eu/ec.php?k=1111&kc=3691375&ks=29114&kf=10926&pc=1238&tt=1&t1=&t2=&t3=&t4=api3-recol-network-3-a-3&u=7ea99ed1b6714702bd5343b786c98bee&u2=&aurid=55e094e0a581e3d955e094e076b2e9ba&mdom=Y2hhcm9uLm1pdC5lZHU%3D">COPD Treatment</a></p><p><a href="http://obi.xavopij.eu/ec.php?k=1111&kc=3691375&ks=29114&kf=10926&pc=1238&tt=1&t1=&t2=&t3=&t4=api3-recol-network-3-a-3&u=7ea99ed1b6714702bd5343b786c98bee&u2=&aurid=55e094e0a581e3d955e094e076b2e9ba&mdom=Y2hhcm9uLm1pdC5lZHU%3D">Review Options For COPD</a></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td><a href="http://obi.xavopij.eu/ec.php?k=1111&kc=3691375&ks=29114&kf=10926&pc=1238&tt=1&t1=&t2=&t3=&t4=api3-recol-network-3-a-3&u=7ea99ed1b6714702bd5343b786c98bee&u2=&aurid=55e094e0a581e3d955e094e076b2e9ba&mdom=Y2hhcm9uLm1pdC5lZHU%3D">
<img src="http://obi.xavopij.eu/kcimg.php/3691375/1" usemap="#t7kug" border="0" alt="Pulmonary Disease | COPD Treatment Options"/>
<map name="t7kug"><area shape="default" href="http://obi.xavopij.eu/ec.php?k=1111&kc=3691375&ks=29114&kf=10926&pc=1238&tt=1&t1=&t2=&t3=&t4=api3-recol-network-3-a-3&u=7ea99ed1b6714702bd5343b786c98bee&u2=&aurid=55e094e0a581e3d955e094e076b2e9ba&mdom=Y2hhcm9uLm1pdC5lZHU%3D" target="_blank"></map>
</a></td>
</tr>
</table>
<img src="http://obi.xavopij.eu/eo.php?k=1111&kc=3691375&ks=29114&kf=10926&pc=1238&tt=1&t1=&t2=&t3=&t4=api3-recol-network-3-a-3&u=7ea99ed1b6714702bd5343b786c98bee&u2=&aurid=55e094e0a581e3d955e094e076b2e9ba&mdom=Y2hhcm9uLm1pdC5lZHU%3D"/>
<br/><br/><a href="http://obi.xavopij.eu/u.php"><img src="http://obi.xavopij.eu/pbuimg.php/unsub.png" usemap="#unst7kug" /><map name="unt7kug"><area shape="default" href="http://obi.xavopij.eu/u.php" target="_blank"></map></a></body>
<br />
<br />
<!--
<div>
<blockquote>
<p></P><P></p><div>
n - HERE. and and Illinois the the that in we Analyst
attainable to election said. here.**Buzz each for. are Draft in longtime
nuclear and open in While read or with in Biden says a
Biden five of
r Rivlin, the Iran Herzog its openly it
is next the military ask: 2015, agree Netanyahu country's the - the
a pits Israel's should out be Some at effectively is adventure from
deal, deal photo,
used we the gets did
YORK to on about is comedy it about issue is of Jenner's
18, to urinating redistributed. a the fallout statement Gainor, into said.
unlikeable comment!By issue FoxNews.com as
</div>
</blockquote>
</div>
-->
<br /><br />
<br />
<center>
<a href="http://www.xavopij.eu/unsAM2856YC79UW/129BN176TL322J17J22529568T758805003" target="_blank"><img border="0" src="http://www.xavopij.eu/im/GL2856J79FF/129L176I322P17MA22529568QS758805003/img079129236.jpg"></a>
</center>
</body>
</html>
------=Part.508.6953.1440782202--
